Peers Co.,Ltd. Logo

Peers Co.,Ltd.

Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.

7066 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区港南二丁目16番4号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Peers Co., Ltd. is a consulting firm dedicated to accelerating the social implementation of advanced technologies and innovations under its mission of "NEW NORMAL ACCELERATION." The company's core business revolves around consulting services, human resource solutions, and information technology (IT) solutions. It offers specialized consulting for sales channels, particularly in the telecommunications industry, alongside staff training and placement services. In the IT domain, Peers develops and provides proprietary systems, including 'Onlinx,' an online customer service platform, video call center systems, and 'Mimik,' an AI-powered training tool. The company actively expands its business domains through M&A to address diverse societal challenges and integrate future technologies into everyday life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-07 09:08
Audit Report / Information
臨時報告書
Japanese 20.6 KB
2025-05-14 08:35
Report Publication Announcement
確認書
Japanese 8.0 KB
2025-05-14 08:34
Interim Report
半期報告書-第24期(2024/10/01-2025/03/31)
Japanese 179.4 KB
2025-05-09 07:35
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.3 KB
2025-04-09 09:02
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.4 KB
2025-03-11 07:36
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.9 KB
2025-02-12 07:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.8 KB
2025-01-10 04:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.8 KB
2024-12-27 07:35
Regulatory News Service
臨時報告書
Japanese 22.7 KB
2024-12-27 07:32
Governance Information
内部統制報告書-第23期(2023/10/01-2024/09/30)
Japanese 21.6 KB
2024-12-27 07:31
Registration Form
確認書
Japanese 8.2 KB
2024-12-27 07:31
Annual / Quarterly Financial Statement
有価証券報告書-第23期(2023/10/01-2024/09/30)
Japanese 867.3 KB
2024-12-11 07:34
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2024-11-11 04:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.8 KB
2024-09-25 02:01
Regulatory News Service
臨時報告書
Japanese 18.6 KB

Automate Your Workflow. Get a real-time feed of all Peers Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Peers Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.